This inventor holds 1 USPTO granted patent. Top assignee: Hanil Pharmaceutical Ind., Co., Ltd.. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Inventor Profile: Jai M Shin
Introduction: Jai M Shin is an accomplished inventor based in Seoul, South Korea. With a strong focus on innovative chemical processes, he has contributed significantly to the field of pharmaceuticals. His work not only showcases his expertise but also highlights the importance of research and development in creating impactful solutions in the industry.
Latest Patents: Jai M Shin holds a patent for a unique process of preparing N'-[4-[[(2-cyanoethyl)thiol]methyl]-2-thiazolyl]guanidine. This innovative process involves reacting a dihaloacetone with a β-cyanoethylthiol in a two-phase solvent system at a pH of 4.5-6.0 to produce a 1-halo-3-(2-cyanoethylthio)propanone. Subsequently, this compound is reacted with amidinothiourea, showcasing a novel approach to chemical synthesis that has potential applications in the pharmaceutical sector.
Career Highlights: Currently, Jai M Shin is employed at Hanil Pharmaceutical Industries Co., Ltd., where he has been instrumental in driving forward various research initiatives. His dedication to advancing pharmaceutical processes is evident in his work, which has contributed to the development of new therapeutic agents.
Collaborations: Jai has had the opportunity to collaborate with talented coworkers, such as Moon G Koh and Dong Soo Kim, further enhancing the innovative environment at Hanil Pharmaceutical. These collaborations have fostered a culture of creativity and problem-solving, essential for successful innovation.
Conclusion: Jai M Shin's contributions to the field of pharmaceuticals exemplify the spirit of innovation and the pursuit of excellence. Through his patented processes and collaborative efforts, he continues to make significant strides that may benefit both the industry and society at large.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile